Skip to main content

Table 1 Clinical profile, laboratory investigation and carotid intimal medial thickness of the participants

From: Relation of serum resistin to subclinical atherosclerosis in multiple sclerosis

Variables

MS sufferers

(n = 114)

Controls

(n = 114)

p value

Age

37.13 ± 7.61

35.11 ± 6.53

0.13

Gender

   

 Male

36 (32%)

40 (35%)

0.57

 Female

78 (68%)

74 (65%)

Disease course

   

 RR

86 (75%)

–

–

 SP

20 (18%)

–

 PP

8 (7%)

–

Smoking

28 (24%)

29 (25%)

0.9

Age of MS onset (years)

27.39 ± 6.79

–

–

Disease duration (years)

4.43 ± 3.31

–

–

Number of relapses

3.46 ± 1.36

–

–

EDSS

2.54 ± 1.81

–

–

Body mass index (kg/m2)

27.68 ± 6.93

26.34 ± 6.91

0.30

Total cholesterol (mg/dl)

184.68 ± 4.13

182.65 ± 4.16

0.0003*

Triglycerides (mg/dl)

138.59 ± 8.94

135.58 ± 8.83

0.01*

High-density lipoprotein (mg/dl)

59.59 ± 6.2

61.17 ± 6.1

0.05

Low-density lipoprotein (mg/dl)

109.23 ± 3.53

108.54 ± 2.39

0.053

Resistin (ng/mL)

15.29 ± 2.76

7.39 ± 2.16

 < 0.0001**

Mean CIMT (mm)

0.57 ± 0.13

0.56 ± 0.11

0.65

Right CIMT (mm)

0.61 ± 0.09

0.57 ± 0.08

0.01*

Left CIMT (mm)

0.53 ± 0.11

0.54 ± 0.11

0.63

  1. MS multiple sclerosis; n number, % percentages; RR relapsing–remitting, SP secondary progressive, PP primary progressive, EDSS expanded disability status scale, CIMT carotid intimal medial thickness
  2. *Significant, **Highly significant